Nephro Care India Management
Management criteria checks 0/4
Nephro Care India's CEO is Pratim Sengupta, appointed in Sep 2024, has a tenure of less than a year. directly owns 61.38% of the company’s shares, worth ₹1.93B. The average tenure of the management team and the board of directors is 0.8 years and 1 years respectively.
Key information
Pratim Sengupta
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 61.4% |
Management average tenure | less than a year |
Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Pratim Sengupta (48 yo)
less than a year
Tenure
Dr. Pratim Sengupta is Managing Director of Nephro Care India Limited (formerly known as Nephro Care India Private Limited) since March 04, 2024 and has been its Director since July 08, 2014 and also serve...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Financial Officer | 1.2yrs | ₹600.00k | 0.14% ₹ 4.3m | |
Company Secretary & Compliance Officer | less than a year | ₹74.00k | no data | |
MD, CEO & Chairman | less than a year | no data | 61.38% ₹ 1.9b |
0.8yrs
Average Tenure
48yo
Average Age
Experienced Management: NEPHROCARE's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD, CEO & Chairman | 10.4yrs | no data | 61.38% ₹ 1.9b | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Non-Executive Non-Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Non Executive Non-Independent Director | 10.4yrs | no data | no data |
1.0yrs
Average Tenure
50yo
Average Age
Experienced Board: NEPHROCARE's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 06:56 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/03/31 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nephro Care India Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|